US

Akira Arimura

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Arimura. Retrieved from https://idiyas.com/inventor/akira-arimura-ielt02gs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akira Arimura: Innovator in Synthetic Peptides

Introduction

Akira Arimura is a notable inventor based in the United States. She has made significant contributions to the field of synthetic peptides, particularly in the development of growth hormone releasing factors. Her innovative work has implications for both animal growth and pharmaceutical applications.

Latest Patents

Arimura holds a patent for a synthetic peptide growth hormone releasing factor. This patent describes a synthetic peptide with a specific amino acid sequence and outlines methods for inducing growth in animals. The patent also includes growth-inducing pharmaceutical compositions, which encompass animal feed compositions.

Career Highlights

Throughout her career, Arimura has focused on advancing the understanding and application of synthetic peptides. Her work has been instrumental in developing new methods for promoting growth in animals, which can have a significant impact on agricultural practices.

Collaborations

Arimura has collaborated with notable colleagues, including Ding Chang and Michael D. Culler. These partnerships have contributed to her research and the successful development of her patented innovations.

Conclusion

Akira Arimura's contributions to the field of synthetic peptides highlight her role as an innovative inventor. Her work continues to influence advancements in animal growth and pharmaceutical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…